original ) (raw )Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
Alessandro Cuomo
BMC Medicine, 2020
View PDFchevron_right
Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
Paul Naarding
The British Journal of Psychiatry
View PDFchevron_right
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review
Udo Bonnet
Journal of Clinical Psychopharmacology
View PDFchevron_right
Pharmacological treatment during CoViD-19 and mental health issues
Sana Rehman
Rivista di psichiatria, 2021
View PDFchevron_right
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics
Massimo Clerici
Human Psychopharmacology: Clinical and Experimental, 2021
View PDFchevron_right
Research in the times of COVID-19
Tudor Florea
2021
View PDFchevron_right
О возможной роли некоторых психотропных препаратов в терапии COVID-19 // On the possible role of some psychotropic medications in the therapy of COVID-19 infection
Peter Morozov , Roman A Bekker , Yuri Bykov
О возможной роли некоторых психотропных препаратов в терапии COVID-19 // On the possible role of some psychotropic medications in the therapy of COVID-19 infection, 2021
View PDFchevron_right
Research Paper: Drug Interactions of Psychiatric and COVID-19 Medications
Alia Shakiba , Basic and Clinical Neuroscience Journal
2020
View PDFchevron_right
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System
Molly Finnerty
JAMA Network Open
View PDFchevron_right
Exploring the Efficacy of Psychotropic Drug Combinations for COVID-19 Depression
Rodrigo Cé
Revista Multidisciplinar em Saúde
View PDFchevron_right
Drug-Drug Interaction between Psychiatric Medications and Experimental Treatments for Coronavirus Disease-19: A Mini-Review
hananeh baradaran
Open Access Macedonian Journal of Medical Sciences
View PDFchevron_right
Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
Parisa Ghasemiyeh
Iranian Journal of Pharmaceutical Research : IJPR, 2021
View PDFchevron_right
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
Chris Kalafatis
Therapeutic Advances in Psychopharmacology
View PDFchevron_right
Drug Interactions of Psychiatric and COVID-19 Medications
Alia Shakiba
Basic and Clinical Neuroscience Journal, 2020
View PDFchevron_right
Psychotropic Prescriptions During the COVID-19 Pandemic Among U.S. Children and Adolescents Receiving Mental Health Services
Susan Dosreis
Journal of Child and Adolescent Psychopharmacology
View PDFchevron_right
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
Nicolas Hoertel
Translational Psychiatry
View PDFchevron_right
Adverse drug reactions associated with concurrent acute psychiatric treatment and Covid-19 drug therapy
Alper BÜLBÜL
International Journal of Psychiatry in Clinical Practice, 2020
View PDFchevron_right
The interface of psychiatry and COVID-19: Challenges for management of psychiatric patients
Afzal Javed
Pakistan Journal of Medical Sciences
View PDFchevron_right
Psychiatric Clinical Profiles and Pharmacological Interactions in COVID-19 Inpatients Referred to a Consultation Liaison Psychiatry Unit: a Cross-Sectional Study
Cristian Llach
Psychiatric Quarterly, 2021
View PDFchevron_right
Use of anxiolytics and hypnotic drugs during COVID-19 pandemic: The literature review
Tea Trajkovski
Medicinski Podmladak, 2022
View PDFchevron_right
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
Milica Borovcanin
Frontiers in Psychiatry, 2020
View PDFchevron_right
Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study
Gloria Aguayo
Frontiers in Public Health, 2023
View PDFchevron_right
COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatry
Cristian Llach
Journal of Affective Disorders, 2020
View PDFchevron_right
Use of psychotropic drugs during the argentine quarantine due to the COVID-19 pandemic
Gerardo A B R A H A M Fridman
Pharmacy & Pharmacology International Journal, 2021
View PDFchevron_right
Psychiatric Evaluation of the Effects of COVID-19
Athenaeum Scientific Publishers | Open Access Journals | Research Journals
Journal of Clinical Medical Research, 2021
View PDFchevron_right
Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
Marta Torrens
Journal of Clinical Medicine
View PDFchevron_right
Depression, Suicidal Ideation, and Consumption of Psychotropic Drugs During Lockdown by COVID-19 According to Gender and Age
Laura Pérez de Vicente
International Journal of Mental Health and Addiction
View PDFchevron_right
Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
Udo Bonnet
Frontiers in Psychiatry, 2023
View PDFchevron_right
Prescriptions of antipsychotics dispensed in long-term care facilities during the COVID-19 pandemic
Iara Oliveira
General Hospital Psychiatry
View PDFchevron_right
Treatment of mental disorders and the course of COVID-19
Katarzyna Korzeniowska
Research Square (Research Square), 2023
View PDFchevron_right
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort
Catherine Clelland
British Journal of Psychiatry Open, 2021
View PDFchevron_right
Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID‐19 Spanish inpatients
Maria Giralt
Acta Psychiatrica Scandinavica, 2021
View PDFchevron_right
Psychotropic drugs consumption during 2020 COVID-19 pandemic and lockdowns: Evidence of a surprising resilience of the drugs delivery system in France
Fanny Gollier-briant
European Neuropsychopharmacology
View PDFchevron_right
Update of the Potential Treatments for Psychiatric and Neuropsychiatric Symptoms in the Context of the Post-COVID-19 Condition: Still a Lot of Suffering and Many More Things to Learn
Guido Bondolfi
Trauma Care, 2022
View PDFchevron_right
Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence From Six Database Programs
Javedh Shareef
Cureus, 2021
View PDFchevron_right